New rules will force EU medtech notified bodies to up their game
This article was originally published in Clinica
The European Commission has adopted two measures that it says are aimed at strengthening the safety of medical devices and restoring consumer confidence in the industry following the PIP breast implant affair. The measures clarify the criteria to be met by notified bodies and the tasks these bodies have to undertake when they perform audits and assessments in the medical devices and in vitro diagnostics sector.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.